OxiWear received its utility and design patents from the United States Patent and Trademark Office. The patent numbers assigned to the product are US-D916291S and US-10987067B2.
“We are excited to receive our utility and design patents for OxiWear,” stated Shavini Fernando, founder and CEO, OxiWear. “Our ear-wearable medical device is designed to help those patients at risk of silent hypoxia. Accomplishing this patent milestone to protect the intellectual property of our invention ensures that we can produce the wearable device in the upcoming months and distribute it to those who need 24-hour, continuous oxygen monitoring.”
OxiWear received its patent approval on April 27, 2021. The process was facilitated with the assistance of Cooley, LLC.
The USPTO serves to protect intellectual property for new products and inventions. The application process includes determining if a product is patentable, applying for specific patents (design, utility, or plant), completing a patent application, working with a federal patent examiner for review of an application, and notification of approval or denial by the patent office.
The first patent received by OxiWear is a utility patent. It is considered the most common patent application and is “granted to anyone who invents or discovers any new and useful process, machine, article, or composition of matters, or any new useful improvement thereof.” The second patent that OxiWear received is a Design Patent. This patent is “granted to anyone who invents a new, original, and ornamental design for an article of manufacture.” For more details on the patent application process, visit: USPTO.